Correlation Between Guided Therapeutics and Sight Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Guided Therapeutics and Sight Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guided Therapeutics and Sight Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guided Therapeutics and Sight Sciences, you can compare the effects of market volatilities on Guided Therapeutics and Sight Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guided Therapeutics with a short position of Sight Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guided Therapeutics and Sight Sciences.

Diversification Opportunities for Guided Therapeutics and Sight Sciences

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Guided and Sight is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Guided Therapeutics and Sight Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sight Sciences and Guided Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guided Therapeutics are associated (or correlated) with Sight Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sight Sciences has no effect on the direction of Guided Therapeutics i.e., Guided Therapeutics and Sight Sciences go up and down completely randomly.

Pair Corralation between Guided Therapeutics and Sight Sciences

Given the investment horizon of 90 days Guided Therapeutics is expected to generate 2.64 times more return on investment than Sight Sciences. However, Guided Therapeutics is 2.64 times more volatile than Sight Sciences. It trades about -0.02 of its potential returns per unit of risk. Sight Sciences is currently generating about -0.12 per unit of risk. If you would invest  20.00  in Guided Therapeutics on September 4, 2024 and sell it today you would lose (4.00) from holding Guided Therapeutics or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Guided Therapeutics  vs.  Sight Sciences

 Performance 
       Timeline  
Guided Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Guided Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent technical indicators, Guided Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Sight Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sight Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Guided Therapeutics and Sight Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Guided Therapeutics and Sight Sciences

The main advantage of trading using opposite Guided Therapeutics and Sight Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guided Therapeutics position performs unexpectedly, Sight Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sight Sciences will offset losses from the drop in Sight Sciences' long position.
The idea behind Guided Therapeutics and Sight Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal